Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 1, 2019

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions
Root Canal Therapy
Interventions
DRUG

Collagen-hydroxyapatite scaffold (Syn-Oss)

The aim of this study is to add to the existing body of regenerative endodontics research by providing human radiographic evidence for the healing process which occurs after the placement of a FDA-approved collagen-hydroxyapatite scaffold, in the use of a blood clot

DRUG

Collagen Scaffold (Colla-Plug)

Traditionally, endodontic therapy consisted of removing the infected dental pulp from the canal spaces and replacing it with an artificial substitute called gutta percha. Regenerative endodontic research efforts were originally concentrated upon treatment of the immature necrotic tooth whereby stem cells from the bone near the root end were stimulated to grow onto a blood clot scaffold created within the debrided and disinfected canal space. The hope is that the stem cells would differentiate into cells which could potentially replace the lost pulpal tissues, restoring what was lost due to infection.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Collagen Matrix

INDUSTRY

lead

University of Alabama at Birmingham

OTHER